The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients.

Background: The standard recommendation for neoadjuvant therapy for human epidermal growth factor receptor-2 (HER2)-positive breast cancer patients is trastuzumab in combination with chemotherapy, but there is no current standard recommendation for appropriate chemotherapy regimens. This meta-analys...

Descripción completa

Detalles Bibliográficos

Publicado en:	Clinical Medicine Insights: Oncology pp. 1 - 13
Autores principales:	Ding, Yuqin, Ding, Kaijing, He, Xiangming, Mo, Wenju, Liang, Chenlu, Gong, Lijie, Huang, Yuting, Ding, Xiaowen
Formato:	meta analysis research systematic review tables/charts Journal Article
Publicado:	Sage Publications Inc. 9/21/2023
Acceso en línea:	Ver este registro en EBSCOhost